Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06281899
PHASE4

Effect of Low Protein Diet on Top of Dapagliflozin on Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus

Sponsor: Anemia Working Group Romania

View on ClinicalTrials.gov

Summary

This is a prospective multicenter randomized controlled trial with a total duration of 36 months aiming to evaluate the effectiveness and the safety of low protein diet on top of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and renin-angiotensin-aldosterone inhibitors (RAASi) in reducing the progression of chronic kidney disease in patients with type 2 Diabetes Mellitus

Official title: Effect of the Low PROtein Diet on Top of DAPAgliflozin and RAASi on the Progression of Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

200

Start Date

2022-01-01

Completion Date

2027-12-31

Last Updated

2026-10-28

Healthy Volunteers

No

Interventions

DRUG

Dapagliflozin 10 mg Tab

Dapagliflozin 10 mg once daily

BEHAVIORAL

Low protein diet

Plant based low protein diet (0.6 g/kg IBW)

Locations (1)

Carol Davila University of Medicine and Pharmacy Bucharest

Bucharest, Romania